UK becomes world's first to roll out Oxford vaccine as cases surge

Britain touted a scientific "triumph" as dialysis patient Brian Pinker, 82, became the first person to get the Oxford/AstraZeneca shot outside of a trial

Coronavirus, vaccine, ASTRAZENECA, OXFORD, covid, drugs, clinical trials
Professor Andrew Pollard, director of the Oxford Vaccine Group, and a professor of paediatric infection and immunity, receives the Oxford-AstraZeneca vaccine at the Churchill Hospital in Oxford | Photo:AP/PTI
Alistair Smout & Guy Faulconbridge | Reuters London
3 min read Last Updated : Jan 05 2021 | 2:20 AM IST
Britain began vaccinating its population with Oxford University and AstraZeneca’s Covid-19 shot on Monday in a world first, racing to give protection to the elderly and vulnerable as a new surge of cases threatened to overwhelm hospitals.

Britain touted a scientific “triumph” as dialysis patient Brian Pinker, 82, became the first person to get the Oxford/AstraZeneca shot outside of a trial. As major powers eye the benefits of being first out of the pandemic, Britain is rushing to vaccinate its population faster than the United States and the rest of Europe, although Russia and China have been inoculating their citizens for months.

Just under a month since Britain became the first country to roll out the vaccine developed by Pfizer and Germany’s BioNTech, Pinker, who has kidney disease, received the Oxford/AstraZeneca shot. “I am so pleased to be getting the Covid vaccine today and really proud that it is one that was invented in Oxford,” Pinker, a retired maintenance manager, said just a few hundred metres from where the vaccine was developed.

Meanwhile, Scientists are not fully confident that vaccines will work on a new variant of the coronavirus found in South Africa, ITV's political editor said on Monday, citing an unidentified scientific adviser to the British government. British Health Secretary Matt Hancock said earlier on Monday that he was incredibly worried about the new variant. 

‘To consider state of emergency in Tokyo’

Japanese PM Yoshihide Suga says vaccine approval is being speeded up and he promised to consider declaring a state of emergency. Tokyo Governor and the governors of Saitama, Chiba and Kanagawa had asked the government Saturday to declare the emergency after the capital saw a record 1,337 cases on New Year's Eve. Meanwhile, China vehemently refuted the US charge that coronavirus was leaked from a bio lab in the country and asserted that the pandemic was likely to have been caused by separate outbreaks in multiple places in the world. PTI

Singapore economy shrinks record 5.8%

Singapore marked its worst ever recession in 2020 due to the Covid-19 pandemic, although contraction moderated in the fourth quarter as the city-state lifted more coronavirus-related curbs, putting the economy on path to a slow and patchy recovery. The bellwether economy shrank 5.8 per cent in 2020, preliminary data showed on Monday, slightly better than the official forecast for a contraction of between 6.5 per cent and 6 per cent. The government has previously said it expects GDP to grow 4 per cent to 6 per cent this year. Reuters


One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Coronavirus VaccineUKAstraZeneca

Next Story